Treatment of Stress Urinary Incontinence Via Smartphone
Primary Purpose
Female Stress Urinary Incontinence
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Smartphone treatment with PFMT
Sponsored by
About this trial
This is an interventional treatment trial for Female Stress Urinary Incontinence focused on measuring female, stress urinary incontinence, treatment, pelvic floor muscle training, smartphone, internet, life style, eHealth
Eligibility Criteria
Inclusion Criteria:
- stress urinary incontinence
- leakage once a week or more often
- duration of symptoms for at least 6 months
- motivation and time to perform a 12 week long treatment with pelvic floor muscle training
- ability to read and write Swedish
- asset to smartphone
- possibility to send and receive email and asset to printer
- accept to be randomized to one of two groups; a treatment group or a waiting list group
Exclusion Criteria:
- participation in our previous internet study
- pregnancy
- former incontinence surgery
- known malignancy in lower abdomen
- difficulties with passing urine
- visual blood in urine
- intermenstrual bleeding
- severe psychiatric diagnosis
- neurological disease with affection on sensibility in legs or lower abdomen
- urge incontinence
Sites / Locations
- Umea University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Smartphone treatment
Waiting list
Arm Description
Smartphone treatment with PFMT.
Waiting list for three months. They receive the smartphone application after follow-up.
Outcomes
Primary Outcome Measures
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.
Secondary Outcome Measures
Usage of Incontinence Aids
Usage of incontinence aids during the last 4 weeks.
Patient Satisfaction
A self-rated question about if the current treatment was sufficient, with three response options
Incontinence Episode Frequency (IEF)
number of incontinence episodes per week
Patient's Global Impression of Improvement Scale (PGI-I)
A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from "very much better" to "very much worse".
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01848938
Brief Title
Treatment of Stress Urinary Incontinence Via Smartphone
Official Title
Treatment of Stress Urinary Incontinence Via Smartphone
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
March 2013 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Umeå University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether treatment of stress urinary incontinence (SUI) via smartphone is effective.
Detailed Description
Female urinary incontinence (UI) is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or jumping.
The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to improvement or cure in two-thirds of patients. In addition, life style changes, such as weight loss when obese, smoking cessation and reduction of fluid intake if high is recommended.
There is a need for new , flexible and easily accessible treatment programmes for female urinary incontinence. In our previous study, we compared two treatment programmes for SUI without face-to-face contact: one internet based and one sent by post, both based on three months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found highly significant improvements (p<0.001) with large effect sizes (>0,8)concerning primary outcomes (symptoms and quality of life scores) but no significant differences between groups. Compared with the postal group, more participants in the internet group perceived they were much or very much improved (40.9% vs 26.5%, p<0.01, reported reduced usage of incontinence aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs 62.9%, p<0.001).
The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular types.
From our previous experience of an Internet-based programme, we have developed a treatment program designed for smartphone. The effect of the treatment programme will be evaluated after three months by comparing the effect in the "smartphone group" with the effect in the "waiting group".
Participants are consecutively recruited through our website. They answer an online screening survey with automated immediated response for initial screening of eligibility criteria. Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours) are sent by post. After that, they answer a web questionnaire and finally they are interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is well informed of the study procedure.
Women are then randomized to either of the two groups. Women in the smartphone group get a smartphone application for iphone or android. Follow-up after three months with a web questionnaire and a leakage diary. After that the waiting group get their smartphone application.
We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in the postal group in our previous study. We also assume that the waiting group will improve in some extent.
To detect a difference between groups, power 80%, 2-side test and significance 0,05, group size as follow
ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each group
ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each group
PGI (patient´s global impression of improvement). 26,5% improves much or very much (smartphone) and 4% (waiting group):39 in each group
We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Female Stress Urinary Incontinence
Keywords
female, stress urinary incontinence, treatment, pelvic floor muscle training, smartphone, internet, life style, eHealth
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
123 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Smartphone treatment
Arm Type
Active Comparator
Arm Description
Smartphone treatment with PFMT.
Arm Title
Waiting list
Arm Type
No Intervention
Arm Description
Waiting list for three months. They receive the smartphone application after follow-up.
Intervention Type
Behavioral
Intervention Name(s)
Smartphone treatment with PFMT
Intervention Description
A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. The treatment period is three months
Primary Outcome Measure Information:
Title
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Description
Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity
Time Frame
baseline, three months
Title
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
Description
The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.
Time Frame
baseline, three months
Secondary Outcome Measure Information:
Title
Usage of Incontinence Aids
Description
Usage of incontinence aids during the last 4 weeks.
Time Frame
three months
Title
Patient Satisfaction
Description
A self-rated question about if the current treatment was sufficient, with three response options
Time Frame
three months
Title
Incontinence Episode Frequency (IEF)
Description
number of incontinence episodes per week
Time Frame
baseline, three months
Title
Patient's Global Impression of Improvement Scale (PGI-I)
Description
A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from "very much better" to "very much worse".
Time Frame
three months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
stress urinary incontinence
leakage once a week or more often
duration of symptoms for at least 6 months
motivation and time to perform a 12 week long treatment with pelvic floor muscle training
ability to read and write Swedish
asset to smartphone
possibility to send and receive email and asset to printer
accept to be randomized to one of two groups; a treatment group or a waiting list group
Exclusion Criteria:
participation in our previous internet study
pregnancy
former incontinence surgery
known malignancy in lower abdomen
difficulties with passing urine
visual blood in urine
intermenstrual bleeding
severe psychiatric diagnosis
neurological disease with affection on sensibility in legs or lower abdomen
urge incontinence
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eva Samuelsson, MD, PhD
Organizational Affiliation
Department of Public Health and Clinical Medicine, Umeå University
Official's Role
Study Chair
Facility Information:
Facility Name
Umea University
City
Umeå
ZIP/Postal Code
S-90185
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
30869644
Citation
Asklund I, Samuelsson E, Hamberg K, Umefjord G, Sjostrom M. User Experience of an App-Based Treatment for Stress Urinary Incontinence: Qualitative Interview Study. J Med Internet Res. 2019 Mar 14;21(3):e11296. doi: 10.2196/11296.
Results Reference
derived
Learn more about this trial
Treatment of Stress Urinary Incontinence Via Smartphone
We'll reach out to this number within 24 hrs